Oncology Biomarkers: Global Markets

Report Code: BIO244A

Publish Date: Jul 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Use code SUMMER at checkout for 50% OFF

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global oncology biomarkers market reached $15.5 billion in 2022, should reach $17.6 billion by 2023 and $35.2 billion by 2028 with a compound annual growth rate (CAGR) of 14.9% during the forecast period of 2023-2028.

Report Includes

  • 21 data tables and 60 additional tables
  • An in-depth analysis of the global oncology biomarkers market
  • Analyses of global market trends, with data from 2020, 2021, 2022, and projections of compound annual growth rates (CAGRs) through 2028
  • Characterization and quantification of biomarkers market by type, profiling technology, application, cancer type, and region
  • Discussion on market drivers, challenges and key market strategies and trends
  • Information on emerging products and technologies, new analytical platforms, novel immunoassays, and bioinformatics tools and discussion on the use of biomarkers in cancer drug development
  • Profiles of the competitive landscape with an overview of competitor growth strategies and opportunities
  • Company profiles of major players within the industry, including Abbott, F. Hoffmann-La Roche Ltd., Merck KGaA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.

Report Scope

This study provides a comprehensive analysis of oncology biomarkers on a global basis. It aims to offer a range of information, from detailed market analyses within cancer types to overall industry trends, to quantify and qualify the market for products and services in the oncology biomarkers segment. Current and projected market forecasts during the forecast period (2023 to 2028) are discussed. Figures for 2023 are estimated, except where actual results have been reported.

This report includes forecasts by biomarker type, cancer type, application, and region from 2023 through 2028. The report also includes an analysis of leading and emerging competitors in the current worldwide oncology biomarkers market. The competitive environment is examined with a particular focus on how new products and technologies influence the current standard of care.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $15.5 billion
Market size forecast $35.2 billion
Growth rate CAGR of 14.9% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Biomarker Type, Application, Cancer Type
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Canada, Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Russia, China, Japan, India, Australia, South Korea, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Indonesia, Latin America, Middle East and Africa
Key Market Drivers
  • Rising Incidence of Cancer
  • Increasing Use of Biomarkers in Drug Discovery and Development
  • Developments in Analytical Technologies and Assay Methods
  • Increased Availability and Ease of Biomarker Testing
  • Support from Regulatory Agencies
Companies studied
AGENDIA INC.ABBOTT
AGILENT TECHNOLOGIES INC.BIOCARTIS
BIOMERIEUXBIO-RAD LABORATORIES INC.
BDEXACT SCIENCES CORP.
F. HOFFMANN-LA ROCHE LTD.GUARDANT HEALTH INC.
HOLOGIC INC.ILLUMINA INC.
LEICA BIOSYSTEMSMERCK KGAA
MYRIAD GENETICS INC.QIAGEN
SIEMENS HEALTHINEERS AGTHERMO FISHER SCIENTIFIC INC.
VERACYTE INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global oncology biomarker market was valued at $15.5 billion in 2022. The market is projected to reach $35.2 billion in 2028, growing at a CAGR of 14.9% during the forecast period.
Biomarkers have attained immense significance in the cancer care spectrum (risk assessment, screening, diagnosis, therapeutic decisions, and monitoring). The market is propelled by intensive research efforts in the field of cancer, aimed toward discovering new treatments and diagnostic methods for screening and disease diagnosis. Moreover, Next generation sequencing (NGS) and gene expression profiling methods in proteomic technologies have led to the rising adoption of biomarkers in the clinical management of cancer patients. Oncology is the focus of major precision medicine trials and studies. There is a lot of interest from pharmaceutical developers in the use of biomarkers in cancer drug development. The creation of companion diagnostic (CDx) tests can improve the quality of treatment and boost this market.
An in-depth analysis of the global oncology biomarkers market, including historical data and market projection on sales by biomarker type, application, cancer type, and region.
North America has the highest market share in the oncology biomarkers market.
F. Hoffmann-La Roche AG, ThermoFisher Scientific, Abbott, Bio-Rad Laboratories, bioMérieux, Siemens Healthineers, Shimadzu Corp., Merck KGaA, Leica Biosystems (part of Danaher Corp.), Myriad Genetics Laboratories Inc., Qiagen N.V., Guardant Health, Illumina Inc., Sysmex Corp., Laboratory Corporation of America Holdings, and others.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Oncology Biomarkers: Global Markets186Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Market Outlook1Free
Chapter- 4: Market and Technology Background9Free
Chapter- 5: Market Dynamics10Free
Chapter- 6: Market Breakdown by Biomarker Type20Free
Chapter- 7: Market Breakdown by Application20Free
Chapter- 8: Market Breakdown by Cancer Type32Free
Chapter- 9: Market Breakdown by Region16Free
Chapter- 10: Impact of COVID-193Free
Chapter- 11: Emerging Trends and Technologies in the Market7Free
Chapter- 12: Competitive Landscape7Free
Chapter- 13: Company Profiles50Free
Chapter- 14: Appendix: Acronyms3Free

Related Reports

Multi-Cancer Diagnostic Tests: Global Market Outlook

Published - Mar 2024 | Publisher - BCC Publishing | Code - MDS101A

This report provides an in-depth analysis of the global multi-cancer diagnostic (MCD) test market. It highlights the current and future market potential of the tests along with a detailed analysis of the drivers and challenges in the market. The report includes the company profiles of the key players with detailed information about their product portfolios and pipeline products.

Global Bioanalytical Testing Services Market

Published - Oct 2023 | Publisher - BCC Publishing | Code - BIO247A

The global bioanalytical testing services market reached $2.9 billion in 2022, should reach $3.2 billion by 2023 and $6.6 billion by 2028 with a compound annual growth rate (CAGR) of 15.2% during the forecast period of 2023-2028.

Cardiac Biomarkers: Technologies and Global Markets

Published - Mar 2023 | Publisher - BCC Publishing | Code - BIO128D

The global market for cardiac biomarkers is estimated to increase from $13.4 billion in 2022 to reach $23.8 billion by 2027, at a compound annual growth rate (CAGR) of 12.2% from 2022 through 2027.

Renal Biomarkers: Technologies and Global Markets

Published - Jan 2023 | Publisher - BCC Publishing | Code - BIO138B

The global market for renal biomarkers is estimated to increase from $1.2 billion in 2022 to reach $1.7 billion by 2027, at a compound annual growth rate (CAGR) of 7.6% from 2022 through 2027.

Recent Reports

In Vitro Diagnostics (IVD) Quality Controls: Global Market

Published - Aug 2024 | Publisher - Partha Sarathi Das | Code - BIO233B

The global market for In Vitro diagnostics quality controls is expected to grow from $1.5 billion in 2024 and is projected to reach $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2024 to 2029.

Life Science Tools and Reagents: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO083E

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

RNAi Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO127C

The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.

Metabolomics: Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO055E

The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.

Global Recombinant Proteins Market

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO254A

The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Hydrogen Storage: Materials, Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - EGY146C

The global market for hydrogen storage materials and technologies is expected to grow from $5.3 billion in 2023 to $7.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Solid State Batteries: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - FCB053B

The global market for solid state batteries is estimated to increase from $274.0 million in 2023 to reach $1.7 billion by 2029, at a compound annual growth rate (CAGR) of 36.7% from 2024 through 2029.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Plastics Recycling: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - PLS031E

The global market for plastic recycling is expected to grow from $42.4 billion in 2024 to $57.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Oncology Biomarkers: Global Markets
Sample Report